Cathepsin K expression in basal cell carcinoma

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages

  Ishida, M ^a   Kojima, F ^a   Okabe, H ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CELL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND; STRATUM CORNEUM; STROMA CELL;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; CATHEPSIN K; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872831819     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04436.x     Document Type: Article

References (13)

1. Garnero P, Borel O, Byrjalsen I, et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998; 273: 32347-32352.
2. Rünger TM, Quintanilla-Dieck MJ, Bhawan J, et al. Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol 2007; 127: 293-297.
3. Quintanilla-Dieck MJ, Codriansky K, Keady M, et al. Cathepsin K in melanoma invasion. J Invest Dermatol 2008; 128: 2281-2288.
4. Yan X, Takahara M, Xie L, et al. Stromal expression of cathepsin K in squamous cell carcinoma. J Eur Acad Dermatol Venereol 2011; 25: 362-365.
5. Xie L, Hayashida S, Yan X, et al. Overexpression of stromal cathepsin K expression correlates with invasiveness of extra-mammary Paget's disease. Eur J Dermatol 2010; 20: 415-416.
6. Kossard S, Epstein EH Jr, Cerio R, et al. Basal cell carcinoma. In:, LeBoit PE, Burg G, Weedon D, Sarasain A, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC Press, Lyon, 2006: 13-19.
7. Mohamed MM, Sloane BF,. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006; 6: 764-775.
8. Jedeszko C, Sloane BF,. Cysteine cathepsins in human cancer. Biol Chem 2004; 385: 1017-1027.
9. Littlewood-Evans AJ, Bilbe G, Bowler WB, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 1997; 57: 5386-5390.
10. Rapa I, Volante M, Cappia S, et al. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol 2006; 125: 847-854.
11. Brubaker KD, Vessella RL, True LD, et al. Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res 2003; 18: 222-230.
12. Ishida M, Kushima R, Okabe H,. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin. J Cutan Pathol 2008; 35: 926-930.
13. Le Gall C, Bellahcène A, Bonnelye E, et al. A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden. Cancer Res 2007; 67: 9894-9902.